Diplomat Pharmacy
DPLO

from June 30, 2019 to September 30, 2019 Issuance of shares of common stock as consideration for InTouch Pharmacy LLC acquisition Stock issued upon stock option exercises Stock issued upon vesting of restricted stock units

from March 31, 2019 to June 30,2019 Stock issued upon stock option exercises Stock issued upon vesting of restricted stock units Restricted stock award activity

From January 1, 2019 to March 31, 2019 Stock issued upon vesting of restricted stock units Restricted stock award activity

from December 31, 2017 to December 31, 2018 Stock issued upon exercises of stock options Stock issued upon vesting of restricted stock units Restricted stock award activity

from January 1, 2018 to September 30, 2018 Stock issued upon stock option exercises Stock issued upon vesting of restricted stock units Restricted stock award activity

from January 1, 2018 to June 30, 2018 Stock issued upon stock option exercises Stock issued upon vesting of restricted stock units Restricted stock award activity

from January 1, 2018 to March 31, 2018 Stock issued upon stock option exercises Stock issued upon vesting of restricted stock units

from December 31, 2016 to December 31, 2017 Issuance of stock as partial consideration in several acquisitions Stock issued upon stock option exercises Restricted stock awards

From January 1, 2017 To September 30, 2017 Issuance of stock as partial consideration of WRB Communications, LLC acquisition Issuance of stock as partial consideration of Accurate Rx Pharmacy Consulting, LLC acquisition Issuance of stock as partial consideration of Focus Rx Pharmacy Services Inc. and Focus Rx Inc. acquisition Stock issued upon stock option exercises Restricted stock awards

From January 1, 2017 to June 30, 2017 Issuance of stock as partial consideration of WRB Communications, LLC Stock issued upon stock option exercises Restricted stock awards

from January 1, 2017 to March 31, 2017 Stock issued upon stock option exercises Restricted stock awards

from December 31, 2015 to December 31, 2016 Issuance of shares of no par common stock upon full contingent consideration payout Issuance of shares of no par common stock as partial consideration of Valley Campus Pharmacy, Inc. aquisition Stock issued upon stock option exercises Restricted stock awards

From January 1, 2016 to September 30, 2016 Issuance of common stock upon full contingent consideration payout Issuance of common stock as partial consideration of Valley Campus Pharmacy, Inc. acquisition Stock issued upon stock option exercises Restricted stock awards

from January 1, 2016 to June 30, 2016 Issuance of common stock upon full contingent consideration payout Issuance of common stock as partial consideration of Valley Campus Pharmacy, Inc. Stock issued upon stock option exercises Restricted stock awards

from January 1, 2016 to March 31, 2016 Stock issued upon stock option exercises

from December 31, 2014 to December 31, 2015 Proceeds from follow-on public offering, net of issuance costs Issuance of shares of no par common stock as partial consideration in BioRx, LLC aquisition Issuance of shares of no par common stock as partial consideration in Burman’s Apothecary, LLC aquisition Stock issued upon stock option exercises Restricted stock awards

from January 1, 2015 to September 30, 2015 Proceeds from public offering, net of issuance costs Stock issued upon stock option exercises Issuance of common stock as partial consideration in BioRx, LLC acquisition Issuance of common stock as partial consideration in Burman’s Apothecary, LLC acquisition

from January 1, 2015 to June 30, 2015 Proceeds from public offering, net of issuance costs Issuance of common stock as partial consideration of BioRx, LLC acquisition Issuance of common stock as partial consideration of Burman’s Apothecary, LLC acquisition Stock issued upon stock option exercises

from January 1, 2015 to March 31, 2015 Proceeds from public offering, net of issuance costs

from December 31, 2013 to December 31, 2014 Redemption of shares of common stock Removal of common stock redemption features Issuance of shares of Class B common stock as partial consideration in aquisition of MedPro Rx, Inc. Issuance of shares of Class B common stock in connection with termination of existing stock redemption agreement Proceeds from initial public offering, net of issuance costs Conversion of capital stock into new shares: Redeemable common stock Series A Preferred Stock Class A and B common stock Restricted stock awards a stock split effected as a stock dividend of 8,500 shares for each share of our common stock to our common shareholders of record immediately prior to the completion of this offering

the conversion of all shares of our Series A Preferred Stock into shares of our Class C Voting Common Stock on a one-for-one basis;the conversion of all shares of our Class A Voting Common Stock, Class B Nonvoting Common Stock and Class C Voting Common Stock into shares of our common stock on a one-for-one basis;a stock split effected as a stock dividend of 8,500 shares for each share of our common stock to our common shareholders of record immediately prior to the completion of this offering

from January 1, 2014 to March 31, 2014 Issuance of preferred stock, net of $1,373 in transaction costs